Phase III, international, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + G) versus gemcitabine (G) for resected pancreatic cancer (APACT): Recurrence patterns.

Vaibhav  Sahai

Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Incyte; Incyte; Incyte; Incyte; Ipsen; Ipsen; Ipsen; Ipsen; Klus Pharma; Klus Pharma; Klus Pharma; Klus Pharma; Newlink Genetics; Newlink Genetics; Newlink Genetics; Newlink Genetics; QED Therapeutics; QED Therapeutics; QED Therapeutics; QED Therapeutics

Research Funding - Agios (Inst); Agios (Inst); Agios (Inst); Agios (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Debiopharm Group (Inst); Debiopharm Group (Inst); Debiopharm Group (Inst); FibroGen (Inst); FibroGen (Inst); FibroGen (Inst); FibroGen (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst)

Josep  Tabernero

Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; BeiGene; BeiGene; BeiGene; BeiGene; Biocartis; Biocartis; Biocartis; Biocartis; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Chugai Pharma; Chugai Pharma; Chugai Pharma; Chugai Pharma; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Genentech; Genentech; Genentech; Genentech; Genmab; Genmab; Genmab; Genmab; HalioDx; HalioDx; HalioDx; HalioDx; Halozyme; Halozyme; Halozyme; Halozyme; Imugene; Imugene; Imugene; Imugene; Inflection Biosciences; Inflection Biosciences; Inflection Biosciences; Inflection Biosciences; Ipsen; Ipsen; Ipsen; Ipsen; Kura Oncology; Kura Oncology; Kura Oncology; Kura Oncology; Lilly; Lilly; Lilly; Lilly; Menarini; Menarini; Menarini; Menarini; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Merrimack; Merrimack; Merrimack; Merrimack; Merus; Merus; Merus; Merus; Molecular Partners; Molecular Partners; Molecular Partners; Molecular Partners; MSD; MSD; MSD; MSD; Novartis; Novartis; Novartis; Novartis; Peptomyc; Peptomyc; Peptomyc; Peptomyc; Pfizer; Pfizer; Pfizer; Pfizer; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics; ProteoDesign; ProteoDesign; ProteoDesign; ProteoDesign; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi; Sanofi; Seagen; Seagen; Seagen; Seagen; Seagen; Seagen; Seagen; Seagen; Servier; Servier; Servier; Servier; Symphogen; Symphogen; Symphogen; Symphogen; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; VCN Biosciences; VCN Biosciences; VCN Biosciences; VCN Biosciences

Eric  Van Cutsem

Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Lilly; Lilly; Lilly; Lilly; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis; Novartis; Novartis; Novartis; Roche; Roche; Roche; Roche; SERVIER; SERVIER; SERVIER; SERVIER

Research Funding - amgen (Inst); amgen (Inst); amgen (Inst); amgen (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Roche (Inst); Roche (Inst); Roche (Inst); Roche (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst); SERVIER (Inst)

Michele  Reni

Honoraria - Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Baxalta/Shire

Consulting or Advisory Role - Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Baxalta/Shire; Celgene; Celgene; Celgene; Celgene; Novartis; Novartis; Novartis; Novartis; Novocure; Novocure; Novocure; Novocure; Pfizer; Pfizer; Pfizer; Pfizer

Research Funding - Celgene; Celgene; Celgene; Celgene

Travel, Accommodations, Expenses - Celgene; Celgene; Celgene; Celgene

Margaret A.  Tempero

Honoraria - Japan Pancreas Society; Japan Pancreas Society; Japan Pancreas Society; Japan Pancreas Society; Oregon Health & Science University (OHSU); Oregon Health & Science University (OHSU); Oregon Health & Science University (OHSU); Oregon Health & Science University (OHSU)

Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Advance Medical; Advance Medical; Advance Medical; Advance Medical; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; BIOPHARM; BIOPHARM; BIOPHARM; BIOPHARM; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); CPRIT; CPRIT; CPRIT; CPRIT; EcoR1 Capital; EcoR1 Capital; EcoR1 Capital; EcoR1 Capital; Eisai; Eisai; Eisai; Eisai; FibroGen (Inst); FibroGen (Inst); FibroGen (Inst); FibroGen (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Ignyta; Ignyta; Ignyta; Ignyta; Immunovia; Immunovia; Immunovia; Immunovia; Merck; Merck; Merck; Merck; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Tocagen; Tocagen; Tocagen; Tocagen

Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst)

Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; BIOPHARM; BIOPHARM; BIOPHARM; BIOPHARM; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; CPRIT; CPRIT; CPRIT; CPRIT; Eisai; Eisai; Eisai; Eisai; Halozyme; Halozyme; Halozyme; Halozyme; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyclics; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Pharmacyte Biotech; Tocagen; Tocagen; Tocagen; Tocagen

Eileen Mary  O'Reilly

Consulting or Advisory Role - Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck

Research Funding - AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst)

Jordan  Berlin

No Relationships to Disclose

Hanno  Riess

Honoraria - Bayer; Bayer; Bayer; Bayer; Celgene; Celgene; Celgene; Celgene; Leo Pharma; Leo Pharma; Leo Pharma; Leo Pharma

Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Pfizer; Pfizer; Pfizer; Pfizer

Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Leo Pharma; Leo Pharma; Leo Pharma; Leo Pharma; Pfizer; Pfizer; Pfizer; Pfizer

David  Goldstein

No Relationships to Disclose

Mingyu  Li

Employment - Celgene; Celgene; Celgene; Celgene

Stock and Other Ownership Interests  - Celgene; Celgene; Celgene; Celgene

Brian  Lu

No Relationships to Disclose

Stefano  Ferrara

Stock and Other Ownership Interests  - Celgene; Celgene; Celgene; Celgene

Honoraria - Celgene; Celgene; Celgene; Celgene

Philip Agop  Philip

Honoraria - Amgen; Amgen; Amgen; Amgen; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Biologics; Biologics; Biologics; Biologics; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Caris MPI; Caris MPI; Caris MPI; Caris MPI; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Lexi Pharma; Lexi Pharma; Lexi Pharma; Lexi Pharma; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Sanofi; Sanofi; Sanofi; Sanofi; SynCoreBio; SynCoreBio; SynCoreBio; SynCoreBio; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences

Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck; Merrimack; Merrimack; Merrimack; Merrimack; novartis; novartis; novartis; novartis; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences

Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck

Research Funding - Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); halozyme (Inst); halozyme (Inst); halozyme (Inst); halozyme (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); incyte (Inst); incyte (Inst); incyte (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); novartis (Inst); novartis (Inst); novartis (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); TYME (Inst); TYME (Inst); TYME (Inst); tyme (Inst); tyme (Inst); TYME (Inst); tyme (Inst); tyme (Inst)

Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; celgene; celgene; celgene; celgene; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals